Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Over-the-counter ivermectin sales proposed in Georgia
ATLANTA, Ga. (Atlanta News First) — A Georgia state lawmaker wants to allow over-the-counter sales of a drug…
Let’s Be Honest About Public Health Guidance – Emily Oster
In the first week of January, the Health and Human Services Department, under Secretary Robert F. Kennedy Jr.,…
Super Greens Supplement Recalled After Dozens Fall Ill
Live It Up © 2026 Superfoods, Inc. January is the time of year when many people vow to…
Chicken sold in 7 states recalled for potential listeria contamination
A Georgia-based food company has recalled thousands of pounds of ready-to-eat chicken products, which were sold in seven…
Supplement Recalled Over Potential ‘Life-Threatening’ Side Effects, FDA Reports
The U.S. Food & Drug Administration has recalled a dietary supplement from Modern Warrior. The recall is due…
Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Jan 15 (Reuters) – The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for…
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
US FDA to limit regulation of health and fitness wearables, commissioner says
By Puyaan Singh Jan 6 (Reuters) – The U.S. Food and Drug Administration said on Tuesday that it…
California to stop paying insurance claims on Ozempic, other GLP-1s
Over half a million Californians could lose access to the hugely popular GLP-1 weight loss drugs starting Jan.…
US FDA declines to approve Corcept’s drug for rare hormonal disorder
By Sneha S K and Sahil Pandey Dec 31 (Reuters) – The U.S. Food and Drug Administration has…
Why Corcept (CORT) Shares Are Falling Today
Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 51.4% in the afternoon session after the U.S. Food and…